Mendota Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Mendota Financial Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-140	Closed	-$72.8K	–	338
2024 Q4	$72.8K	Sell	140 -73	-34%	-$40.1K	0.05%	122
2024 Q3	$132K	Buy	213 +3	+1%	+$1.78K	0.06%	100
2024 Q2	$116K	Hold	210	–	–	0.06%	112
2024 Q1	$122K	Hold	210	–	–	0.07%	109
2023 Q4	$111K	Sell	210 -2	-0.9%	-$968	0.09%	141
2023 Q3	$107K	Hold	212	–	–	0.11%	89
2023 Q2	$111K	Buy	212 +72	+51%	+$38.9K	0.12%	81
2023 Q1	$82.7K	Sell	140 -72	-34%	-$40.6K	0.08%	109
2022 Q4	$117K	Buy	+212	New	+$112K	0.15%	81

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Mendota Financial Group's TMO Position: Q1 2025 in Review

Mendota Financial Group sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 140 shares — an estimated $72.8K sold.

Mendota Financial Group first reported a position in TMO in Q4 2022 and held it in 9 quarters. The position peaked at $132K in Q3 2024. 2,570 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

Mendota Financial Group reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
Mendota Financial Group sold 140 Thermo Fisher Scientific shares in Q1 2025, an estimated $72.8K.
Mendota Financial Group first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 9 quarters.
Mendota Financial Group's Thermo Fisher Scientific position peaked at $132K in Q3 2024.
2,570 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Mendota Financial Group's 13F filing for Q1 2025, filed 22 Apr 2025.